Hypofractionated stereotactic radiotherapy for oligometastatic patients: developing of a response predictive model.

Barbara DilettoNicola DinapoliSilvia ChiesaGian Carlo MattiucciVincenzo FrascinoCarmelo AnileCesare ColosimoVincenzo ValentiniMario Balducci

Published in: Medical oncology (Northwood, London, England) (2018)

The ratio between BED10 and the logarithm of metastasis volume (BVR), as a corrective factor for fitting the probability of metastases response to stereotactic radiotherapy, could be a tool for evaluating and prescribing treatments for oligometastatic disease. BVR can be useful for producing more reliable survival statistics too.

Keyphrases

radiation therapy
early stage
end stage renal disease
brain metastases
ejection fraction
locally advanced
primary care
newly diagnosed
chronic kidney disease
radiation induced
prognostic factors
emergency department
small cell lung cancer
patient reported